Advertisement

Advertisement

CBLL Stock Latest News

Ceribell receives 510(k) premarket notification for brain monitor headband

The FlyCeribell receives 510(k) premarket notification for brain monitor headband

Ceribell Earnings Call Highlights Strong Growth, Rising Costs

PremiumCompany Announcements

Ceribell Earnings Call Highlights Strong Growth, Rising Costs

1M ago

Ceribell price target lowered to $28 from $30 at Canaccord

PremiumThe Fly

Ceribell price target lowered to $28 from $30 at Canaccord

2M ago

Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating

PremiumRatings

Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating

2M ago

Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating

PremiumRatings

Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating

2M ago

Ceribell reports Q4 EPS (36c), consensus (41c)

PremiumThe FlyCeribell reports Q4 EPS (36c), consensus (41c)

2M ago

Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M

The Fly

Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M

2M ago

CBLL Earnings this Week: How Will it Perform?

Pre-Earnings

CBLL Earnings this Week: How Will it Perform?

2M ago

Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook

PremiumRatings

Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook

2M ago

Ceribell: Expanding Neurology Platform, Growing TAM, and Attractive Valuation Support Buy Rating

PremiumRatings

Ceribell: Expanding Neurology Platform, Growing TAM, and Attractive Valuation Support Buy Rating

3M ago

Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity

PremiumRatings

Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity

3M ago

Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool

PremiumCompany Announcements

Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool

3M ago

Ceribell receives FDA breakthrough device designation for LVO SD monitor

PremiumThe FlyCeribell receives FDA breakthrough device designation for LVO SD monitor

3M ago

Ceribell director resigns to pursue other professional ventures

Company Announcements

Ceribell director resigns to pursue other professional ventures

3M ago

Ceribell price target raised to $30 from $29 at Canaccord

The Fly

Ceribell price target raised to $30 from $29 at Canaccord

4M ago

Ceribell, Inc. Extends Sunnyvale Office Leases

PremiumCompany Announcements

Ceribell, Inc. Extends Sunnyvale Office Leases

4M ago

Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance

PremiumRatings

Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance

4M ago

Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating

PremiumRatings

Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating

4M ago

Ceribell’s FDA Clearance Boosts Market Prospects and Expands Multi-Indication Platform

PremiumRatings

Ceribell’s FDA Clearance Boosts Market Prospects and Expands Multi-Indication Platform

4M ago

Ceribell price target raised to $29 from $20 at TD Cowen

PremiumThe FlyCeribell price target raised to $29 from $20 at TD Cowen

4M ago

Ceribell, Inc. Gains FDA Clearance for Delirium Device

Company Announcements

Ceribell, Inc. Gains FDA Clearance for Delirium Device

4M ago

Ceribell receives FDA 510k clearance for delirium screening, monitoring device

The Fly

Ceribell receives FDA 510k clearance for delirium screening, monitoring device

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >